X4 Pharmaceuticals is a publicly traded biopharmaceutical enterprise listed on the NASDAQ exchange under the ticker symbol XFOR, meaning it is collectively owned by its public shareholders, institutional investment funds, asset management firms, and mutual funds. Major institutional stakeholders hold sizeable equity portions, while executive management teams and company insiders retain individual shares. The corporation operates independently under an elected board of directors rather than being owned by a single private entity.